Bonadona V - Search Results

1

Prognosis of early-onset breast cancer based on BRCA1/2 mutation status in a French population-based cohort and review.

Bonadona V, Dussart-Moser S, Voirin N, Sinilnikova OM, Mignotte H, Mathevet P, Brémond A, Treilleux I, Martin A, Romestaing P, Raudrant D, Rudigoz RC, Lenoir GM, Lasset C. Bonadona V, et al. Breast Cancer Res Treat. 2007 Jan;101(2):233-45. doi: 10.1007/s10549-006-9288-7. Epub 2006 Oct 24. Breast Cancer Res Treat. 2007. PMID: 17061047

2

Correlation between clinical response to interleukin 2 and HLA phenotypes in patients with metastatic renal cell carcinoma.

Bain C, Merrouche Y, Puisieux I, Blay JY, Negrier S, Bonadona V, Lasset C, Lanier F, Duc A, Gebuhrer L, Philip T, Favrot MC. Bain C, et al. Among authors: bonadona v. Br J Cancer. 1997;75(2):283-6. doi: 10.1038/bjc.1997.46. Br J Cancer. 1997. PMID: 9010039 Free PMC article.

3

Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC).

Mignotte H, Lasset C, Bonadona V, Lesur A, Luporsi E, Rodier JF, Cutuli B, Lasry S, Mauriac L, Granon C, Kerr C, Giard S, Hill C, de Lafontan B, de Gislain C, D'Anjou J, Fondrinier E, Lefeuvre C, Parache RM, Chauvin F. Mignotte H, et al. Among authors: bonadona v. Int J Cancer. 1998 May 4;76(3):325-30. doi: 10.1002/(sici)1097-0215(19980504)76:3<325::aid-ijc7>3.0.co;2-x. Int J Cancer. 1998. PMID: 9579567 Free article.

4

Prognosis of tamoxifen-associated endometrial cancer.

Lasset C, Mignotte H, Bonadona V, Chauvin F. Lasset C, et al. Among authors: bonadona v. J Clin Oncol. 1998 Jul;16(7):2573. J Clin Oncol. 1998. PMID: 9667283 No abstract available.

5

Risk of endometrial cancer in premenopausal women on tamoxifen.

Lasset C, Bonadona V, Chauvin F, Mignotte H, Brémond A. Lasset C, et al. Among authors: bonadona v. Lancet. 1998 Oct 31;352(9138):1476. doi: 10.1016/S0140-6736(05)61308-6. Lancet. 1998. PMID: 9808024 No abstract available.

6

Tamoxifen and risk of endometrial cancer.

Lasset C, Bonadona V, Mignotte H, Brémond A. Lasset C, et al. Among authors: bonadona v. Lancet. 2001 Jan 6;357(9249):66-7. doi: 10.1016/S0140-6736(05)71563-4. Lancet. 2001. PMID: 11197379 No abstract available.

7

[Medical management of women with inherited predisposition to breast cancer: indications and procedures for mammographic screening].

Lassetn C, Bonadona V. Lassetn C, et al. Among authors: bonadona v. Bull Cancer. 2001 Jul;88(7):677-86. Bull Cancer. 2001. PMID: 11495821 Free article. Review. French.

8

Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result.

Bonadona V, Saltel P, Desseigne F, Mignotte H, Saurin JC, Wang Q, Sinilnikova O, Giraud S, Freyer G, Plauchu H, Puisieux A, Lasset C. Bonadona V, et al. Cancer Epidemiol Biomarkers Prev. 2002 Jan;11(1):97-104. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 11815406

9

Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO.

Bonadona V, Sinilnikova OM, Lenoir GM, Lasset C. Bonadona V, et al. J Natl Cancer Inst. 2002 Oct 16;94(20):1582-3; author reply 1583-4. doi: 10.1093/jnci/94.20.1582. J Natl Cancer Inst. 2002. PMID: 12381714 No abstract available.

10

[Inherited predisposition to breast cancer: after the BRCA1 and BRCA2 genes, what next?].

Bonadona V, Lasset C. Bonadona V, et al. Bull Cancer. 2003 Jul;90(7):587-94. Bull Cancer. 2003. PMID: 12957799 Free article. Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

119 results

Search Page